64 related articles for article (PubMed ID: 18211920)
1. Identification of beta1,4GalT II as a target gene of p53-mediated HeLa cell apoptosis.
Zhou J; Wei Y; Liu D; Ge X; Zhou F; Jiang XY; Gu J
J Biochem; 2008 Apr; 143(4):547-54. PubMed ID: 18211920
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the beta1,4-Galactosyltransferase I promoter by E2F1.
Wei Y; Zhou F; Ge Y; Chen H; Cui C; Liu D; Yang Z; Wu G; Shen J; Gu J; Jiang J
J Biochem; 2010 Sep; 148(3):263-71. PubMed ID: 20538716
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of beta1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells.
Jiang J; Shen J; Wu T; Wei Y; Chen X; Zong H; Zhang S; Sun M; Xie J; Kong X; Yang Y; Shen A; Wang H; Gu J
Glycobiology; 2006 Nov; 16(11):1045-51. PubMed ID: 16873896
[TBL] [Abstract][Full Text] [Related]
4. beta4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization.
Jiang J; Zhou J; Wei Y; Shen J; Liu D; Chen X; Zhang S; Kong X; Yun X; Gu J
Biochem Biophys Res Commun; 2007 Jun; 358(1):41-6. PubMed ID: 17470362
[TBL] [Abstract][Full Text] [Related]
5. Beta1,4-galactosyltransferase V A growth regulator in glioma.
Jiang J; Gu J
Methods Enzymol; 2010; 479():3-23. PubMed ID: 20816157
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of beta1,4GalT V at protein level contributes to arsenic trioxide-induced glioma cell apoptosis.
Wei Y; Liu D; Ge Y; Zhou F; Xu J; Chen H; Yun X; Gu J; Jiang J
Cancer Lett; 2008 Aug; 267(1):96-105. PubMed ID: 18439752
[TBL] [Abstract][Full Text] [Related]
7. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression in apoptosis: identification of ribosomal protein S29 as an apoptotic inducer.
Khanna N; Reddy VG; Tuteja N; Singh N
Biochem Biophys Res Commun; 2000 Oct; 277(2):476-86. PubMed ID: 11032747
[TBL] [Abstract][Full Text] [Related]
9. Beta1,4-galactosyltransferase V regulates self-renewal of glioma-initiating cell.
Wei Y; Zhou F; Ge Y; Chen H; Cui C; Li Q; Liu D; Yang Z; Wu G; Sun S; Gu J; Jiang J
Biochem Biophys Res Commun; 2010 Jun; 396(3):602-7. PubMed ID: 20417617
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
11. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.
Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T
Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
[TBL] [Abstract][Full Text] [Related]
13. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
14. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
15. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
16. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
[TBL] [Abstract][Full Text] [Related]
17. DNA damage-induced modulation of GLUT3 expression is mediated through p53-independent extracellular signal-regulated kinase signaling in HeLa cells.
Watanabe M; Naraba H; Sakyo T; Kitagawa T
Mol Cancer Res; 2010 Nov; 8(11):1547-57. PubMed ID: 20870738
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
[TBL] [Abstract][Full Text] [Related]
19. p53 represses SV40 transcription by preventing formation of transcription complexes.
Perrem K; Rayner J; Voss T; Sturzbecher H; Jackson P; Braithwaite A
Oncogene; 1995 Oct; 11(7):1299-307. PubMed ID: 7478550
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
